Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam plus remifentanil versus propofol plus remifentanil for anesthesia in aesthetic surgery
ChiCTR2500095406Phase 4Not yet recruiting
- Sponsor
- Peking University International Hospital
- Start
- Jan 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of remimazolam, propofol and remifentanil (2 arms), sponsored by Peking University International Hospital. Primary endpoint: Incidence of intraoperative hypoxemia. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
remimazolampropofolremifentanil
Beyond the preview
Go deeper on ChiCTR2500095406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500095406.